Azenta, Inc. (AZTA)
USD 49.65
(7.21%)
USD 49.65
(7.21%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 336.26 Million USD | 25.26% |
| 2022 | 279.6 Million USD | 1.86% |
| 2021 | 274.51 Million USD | -8.56% |
| 2020 | 300.2 Million USD | 11.88% |
| 2019 | 268.32 Million USD | 25.41% |
| 2018 | 213.95 Million USD | 6.94% |
| 2017 | 200.06 Million USD | 10.04% |
| 2016 | 181.8 Million USD | 8.54% |
| 2015 | 167.5 Million USD | 2.29% |
| 2014 | 163.74 Million USD | 10.24% |
| 2013 | 148.53 Million USD | -5.77% |
| 2012 | 157.62 Million USD | 10.7% |
| 2011 | 142.38 Million USD | 21.95% |
| 2010 | 116.75 Million USD | -4.95% |
| 2009 | 122.83 Million USD | -65.59% |
| 2008 | 357.01 Million USD | 107.4% |
| 2007 | 172.13 Million USD | -18.69% |
| 2006 | 211.7 Million USD | 42.06% |
| 2005 | 149.02 Million USD | -11.07% |
| 2004 | 167.56 Million USD | -22.35% |
| 2003 | 215.8 Million USD | -68.07% |
| 2002 | 675.83 Million USD | 261.46% |
| 2001 | 186.97 Million USD | 29.83% |
| 2000 | 144.01 Million USD | 123.63% |
| 1999 | 64.4 Million USD | 12.39% |
| 1998 | 57.3 Million USD | 80.19% |
| 1997 | 31.8 Million USD | 13.98% |
| 1996 | 27.9 Million USD | 114.62% |
| 1995 | 13 Million USD | 78.08% |
| 1994 | 7.3 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 87.06 Million USD | 3.83% |
| 2024 Q3 | 81.74 Million USD | 4.28% |
| 2024 Q2 | 80.36 Million USD | -7.7% |
| 2023 Q3 | 84.43 Million USD | 3.14% |
| 2023 FY | 350.23 Million USD | 25.26% |
| 2023 Q1 | 100.08 Million USD | 38.34% |
| 2023 Q4 | 83.85 Million USD | -0.68% |
| 2023 Q2 | 81.85 Million USD | -18.21% |
| 2022 Q2 | 75.41 Million USD | 12.23% |
| 2022 FY | 279.6 Million USD | 1.86% |
| 2022 Q1 | 67.19 Million USD | -22.81% |
| 2022 Q4 | 72.35 Million USD | 11.92% |
| 2022 Q3 | 64.64 Million USD | -14.27% |
| 2021 Q2 | 96.67 Million USD | 17.74% |
| 2021 FY | 274.51 Million USD | -8.56% |
| 2021 Q4 | 87.05 Million USD | -7.56% |
| 2021 Q3 | 94.16 Million USD | -2.6% |
| 2021 Q1 | 82.11 Million USD | 5.81% |
| 2020 Q4 | 77.6 Million USD | 5.28% |
| 2020 Q1 | 73.74 Million USD | 7.92% |
| 2020 Q3 | 73.71 Million USD | -1.88% |
| 2020 FY | 300.2 Million USD | 11.88% |
| 2020 Q2 | 75.13 Million USD | 1.88% |
| 2019 Q4 | 68.33 Million USD | 2.25% |
| 2019 Q1 | 66.68 Million USD | 14.16% |
| 2019 Q3 | 66.83 Million USD | 0.54% |
| 2019 Q2 | 66.47 Million USD | -0.32% |
| 2019 FY | 268.32 Million USD | 25.41% |
| 2018 Q2 | 60.36 Million USD | 11.01% |
| 2018 FY | 213.95 Million USD | 6.94% |
| 2018 Q1 | 54.37 Million USD | -3.63% |
| 2018 Q3 | 62.46 Million USD | 3.48% |
| 2018 Q4 | 58.41 Million USD | -6.47% |
| 2017 FY | 200.06 Million USD | 10.04% |
| 2017 Q3 | 51.97 Million USD | 6.37% |
| 2017 Q4 | 56.42 Million USD | 8.56% |
| 2017 Q2 | 48.86 Million USD | 14.15% |
| 2017 Q1 | 42.8 Million USD | -2.55% |
| 2016 FY | 181.8 Million USD | 8.54% |
| 2016 Q3 | 44.67 Million USD | -2.47% |
| 2016 Q2 | 45.8 Million USD | -3.37% |
| 2016 Q1 | 47.39 Million USD | 13.79% |
| 2016 Q4 | 43.92 Million USD | -1.67% |
| 2015 FY | 167.5 Million USD | 2.29% |
| 2015 Q3 | 40.65 Million USD | -3.85% |
| 2015 Q2 | 42.28 Million USD | -1.43% |
| 2015 Q4 | 41.65 Million USD | 2.45% |
| 2015 Q1 | 42.9 Million USD | 6.2% |
| 2014 Q1 | 39.96 Million USD | 1.12% |
| 2014 Q2 | 41.13 Million USD | 2.93% |
| 2014 Q4 | 40.39 Million USD | -7.21% |
| 2014 Q3 | 43.53 Million USD | 5.84% |
| 2014 FY | 163.74 Million USD | 10.24% |
| 2013 Q2 | 36.81 Million USD | -1.73% |
| 2013 FY | 148.53 Million USD | -5.77% |
| 2013 Q4 | 39.52 Million USD | 13.77% |
| 2013 Q3 | 34.73 Million USD | -5.65% |
| 2013 Q1 | 37.46 Million USD | -16.93% |
| 2012 Q2 | 36.79 Million USD | -4.89% |
| 2012 Q3 | 37.03 Million USD | 0.64% |
| 2012 Q4 | 45.09 Million USD | 21.77% |
| 2012 FY | 157.62 Million USD | 10.7% |
| 2012 Q1 | 38.69 Million USD | -2.35% |
| 2011 Q2 | 34.68 Million USD | 3.93% |
| 2011 FY | 142.38 Million USD | 21.95% |
| 2011 Q4 | 39.62 Million USD | 14.19% |
| 2011 Q1 | 33.37 Million USD | 2.32% |
| 2011 Q3 | 34.7 Million USD | 0.04% |
| 2010 Q1 | 26.52 Million USD | 2.21% |
| 2010 FY | 116.75 Million USD | -4.95% |
| 2010 Q2 | 28.51 Million USD | 7.54% |
| 2010 Q3 | 29.1 Million USD | 2.04% |
| 2010 Q4 | 32.61 Million USD | 12.09% |
| 2009 FY | 122.83 Million USD | -65.59% |
| 2009 Q4 | 25.94 Million USD | -4.29% |
| 2009 Q3 | 27.1 Million USD | -17.54% |
| 2009 Q1 | 36.91 Million USD | -84.5% |
| 2009 Q2 | 32.87 Million USD | -10.94% |
| 2008 FY | 357.01 Million USD | 107.4% |
| 2008 Q4 | 238.12 Million USD | 563.18% |
| 2008 Q3 | 35.9 Million USD | -13.37% |
| 2008 Q2 | 41.44 Million USD | -0.21% |
| 2008 Q1 | 41.53 Million USD | 0.16% |
| 2007 FY | 172.13 Million USD | -18.69% |
| 2007 Q4 | 41.46 Million USD | -2.98% |
| 2007 Q3 | 42.74 Million USD | -2.51% |
| 2007 Q2 | 43.84 Million USD | -0.56% |
| 2007 Q1 | 44.08 Million USD | -25.46% |
| 2006 Q1 | 46.82 Million USD | 23.58% |
| 2006 FY | 211.7 Million USD | 42.06% |
| 2006 Q3 | 54.46 Million USD | 7.23% |
| 2006 Q2 | 50.79 Million USD | 8.48% |
| 2006 Q4 | 59.14 Million USD | 8.59% |
| 2005 Q3 | 37.3 Million USD | -1.55% |
| 2005 Q1 | 37.65 Million USD | -26.48% |
| 2005 FY | 149.02 Million USD | -11.07% |
| 2005 Q4 | 37.88 Million USD | 1.55% |
| 2005 Q2 | 37.89 Million USD | 0.63% |
| 2004 Q2 | 39.04 Million USD | 697.61% |
| 2004 Q4 | 51.21 Million USD | 26.38% |
| 2004 Q1 | -6.53 Million USD | -108.65% |
| 2004 Q3 | 40.52 Million USD | 3.8% |
| 2004 FY | 167.56 Million USD | -22.35% |
| 2003 Q1 | 55.82 Million USD | -89.81% |
| 2003 FY | 215.8 Million USD | -68.07% |
| 2003 Q4 | 75.52 Million USD | 85.38% |
| 2003 Q3 | 40.74 Million USD | -6.81% |
| 2003 Q2 | 43.71 Million USD | -21.69% |
| 2002 FY | 675.83 Million USD | 261.46% |
| 2002 Q1 | 36.67 Million USD | -33.44% |
| 2002 Q2 | 37.07 Million USD | 1.1% |
| 2002 Q3 | 54.44 Million USD | 46.85% |
| 2002 Q4 | 547.63 Million USD | 905.85% |
| 2001 Q2 | 44.46 Million USD | 1.25% |
| 2001 Q4 | 55.09 Million USD | 18.3% |
| 2001 Q3 | 46.56 Million USD | 4.72% |
| 2001 FY | 186.97 Million USD | 29.83% |
| 2001 Q1 | 43.92 Million USD | -9.07% |
| 2000 Q4 | 48.3 Million USD | 38.45% |
| 2000 Q1 | 22.2 Million USD | -15.27% |
| 2000 Q3 | 34.88 Million USD | 7.45% |
| 2000 Q2 | 32.47 Million USD | 46.26% |
| 2000 FY | 144.01 Million USD | 123.63% |
| 1999 FY | 64.4 Million USD | 12.39% |
| 1999 Q4 | 26.2 Million USD | 85.82% |
| 1999 Q3 | 14.1 Million USD | 11.9% |
| 1999 Q2 | 12.6 Million USD | 9.57% |
| 1999 Q1 | 11.5 Million USD | -59.36% |
| 1998 Q2 | 9.9 Million USD | -8.33% |
| 1998 Q1 | 10.8 Million USD | 10.2% |
| 1998 FY | 57.3 Million USD | 80.19% |
| 1998 Q4 | 28.3 Million USD | 240.96% |
| 1998 Q3 | 8.3 Million USD | -16.16% |
| 1997 Q3 | 8.3 Million USD | 12.16% |
| 1997 Q2 | 7.4 Million USD | 17.46% |
| 1997 Q4 | 9.8 Million USD | 18.07% |
| 1997 FY | 31.8 Million USD | 13.98% |
| 1997 Q1 | 6.3 Million USD | -18.18% |
| 1996 Q4 | 7.7 Million USD | 4.05% |
| 1996 FY | 27.9 Million USD | 114.62% |
| 1996 Q3 | 7.4 Million USD | 4.23% |
| 1996 Q2 | 7.1 Million USD | 0.0% |
| 1996 Q1 | - USD | 100.0% |
| 1995 FY | 13 Million USD | 78.08% |
| 1995 Q4 | -39.1 Million USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1994 FY | 7.3 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | -222.495% |
| AngioDynamics, Inc. | 252.41 Million USD | -33.219% |
| AtriCure, Inc. | 327.05 Million USD | -2.817% |
| Avinger, Inc. | 18.63 Million USD | -1704.196% |
| BioLife Solutions, Inc. | 117.57 Million USD | -185.996% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 81.572% |
| Daxor Corporation | 1.28 Million USD | -26160.216% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -1290.046% |
| Femasys Inc. | 15.2 Million USD | -2112.23% |
| GlucoTrack, Inc. | 7.1 Million USD | -4633.474% |
| Harvard Bioscience, Inc. | 58.58 Million USD | -474.019% |
| Hologic, Inc. | 1.34 Billion USD | 75.003% |
| ICU Medical, Inc. | 717.04 Million USD | 53.104% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 88.65% |
| KORU Medical Systems, Inc. | 26.1 Million USD | -1187.987% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | -272.235% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 281897.384% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 281897.384% |
| Masimo Corporation | 867 Million USD | 61.215% |
| Microbot Medical Inc. | 9.85 Million USD | -3312.136% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -1725.542% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 26.887% |
| Nephros, Inc. | 9.78 Million USD | -3336.897% |
| NovoCure Limited | 613.92 Million USD | 45.227% |
| NEXGEL, Inc. | 4.09 Million USD | -8109.619% |
| NEXGEL, Inc. | 4.09 Million USD | -8109.619% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | -228.889% |
| OraSure Technologies, Inc. | 125.34 Million USD | -168.279% |
| Pro-Dex, Inc. | 7.37 Million USD | -4457.685% |
| Pulse Biosciences, Inc. | 43.57 Million USD | -671.712% |
| Predictive Oncology Inc. | 15.22 Million USD | -2107.987% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -3845.807% |
| QuidelOrtho Corporation | 1.35 Billion USD | 75.189% |
| Repligen Corporation | 261.12 Million USD | -28.777% |
| Sanara MedTech Inc. | 61.12 Million USD | -450.109% |
| STAAR Surgical Company | 224.55 Million USD | -49.748% |
| Sharps Technology, Inc. | 10.12 Million USD | -3220.605% |
| Utah Medical Products, Inc. | 13.26 Million USD | -2435.751% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 81.256% |
| Jin Medical International Ltd. | 3.91 Million USD | -8483.531% |